Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized, double-blind, 12‑month study of pregabalin in restless legs syndrome
2008-005889-32Phase 3Completed
- Sponsor
- Pfizer
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pregabalin in restless legs syndrome (RLS) (3 arms), sponsored by Pfizer. Started May 2009; status: completed.
02
Drugs
pregabalin
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on 2008-005889-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005889-32.